Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Coya Therapeutics, Inc. (COYA) had Weighted-Average Shares Outstanding (Diluted) of 16.72M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.26M |
|
$-7.31M |
|
-- |
|
$0.26M |
|
$7.93M |
|
$-7.68M |
|
$0.37M |
|
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-7.68M |
|
$-7.67M |
|
16.72M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
16.72M |
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$38.37M |
|
$0.03M |
|
$0.03M |
|
$38.41M |
|
$4.34M |
|
-- |
|
$0.69M |
|
$5.04M |
|
$33.37M |
|
$33.37M |
|
$33.37M |
|
16.73M |
|
| Cash Flow Statement Financials | |
$-2.83M |
|
-- |
|
$0.02M |
|
$38.34M |
|
$35.53M |
|
$-2.81M |
|
$1.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2976.89% |
|
-2976.89% |
|
-- |
|
-2833.35% |
|
-2833.35% |
|
$-2.83M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-21.90% |
|
-21.90% |
|
-19.03% |
|
-21.90% |
|
$2.00 |
|
$-0.17 |
|
$-0.17 |
|